Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
8.22
+0.24 (3.01%)
At close: Oct 19, 2026, 4:00 PM EDT
8.35
+0.13 (1.58%)
Pre-market: Oct 20, 2026, 7:52 AM EDT
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $681.46 million as of October 19, 2026. It is the 12,539th most valuable company in the world and the 2,505th biggest in the United States. Its market cap has increased by 626.90% in one year.
Market Cap
681.46M
Enterprise Value
450.36M
1-Year Change
626.90%
Global Rank
Country Rank
#2,505 United States
Category
ChartMarket Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $681.46M, an increase of 936.55%. That is a compound annual growth rate of 62.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 681.46M | 147.27% |
| Dec 31, 2025 | 275.60M | 355.41% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 691.58M |
| Sana Biotechnology | 679.55M |
| Lexicon Pharmaceuticals | 676.33M |
| 4D Molecular Therapeutics | 670.66M |
| OmniAb | 667.34M |
| Pharming Group | 667.25M |
| Achieve Life Sciences | 656.52M |
| Annexon | 646.46M |